Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal antiinflammatory drugs.

Peluffo, Guillermo D; Stillitani, Isabel; Rodríguez, Vanina A; Diament, Miriam J; Klein, Slobodanka M

Peluffo, Guillermo D; Stillitani, Isabel; Rodríguez, Vanina A; Diament, Miriam J; Klein, Slobodanka M.

Affiliation

Peluffo GD; Departamento Bioterio y Cáncer Experimental, Area Investigación, Instituto de Oncología Angel H. Roffo, Universidad de Buenos Aires, Av. San Martín 5481, 1417 Buenos Aires, Argentina. bioterioroffo@yehoo.com

Int J Cancer ; 110(6): 825-30, 2004 Jul 20.

Article in En | MEDLINE | ID: mdl-15170663

Subject(s)

Adenocarcinoma/drug therapy; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Lung Neoplasms/drug therapy; Paraneoplastic Syndromes/prevention & control; Adenocarcinoma/pathology; Animals; Cell Division/drug effects; Cell Survival/drug effects; Chemotaxis/drug effects; Cyclooxygenase Inhibitors/therapeutic use; Cytokines/analysis; Disease Progression; Female; Indomethacin/therapeutic use; Lactones/therapeutic use; Lung Neoplasms/pathology; Male; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness/prevention & control; Sulfones

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Paraneoplastic Syndromes / Adenocarcinoma / Anti-Inflammatory Agents, Non-Steroidal / Lung Neoplasms Limits: Animals Language: En Journal: Int J Cancer Year: 2004 Document type: Article

Search on Google

XML

PubMed Links